Presentations

      Overview of the ABOUT™—Perceived Risk Development and Evolution

      Clerc, E.

      Conference date
      Sep 29, 2022
      Conference name
      CROM Virtual Workshop 2022
      Topic
      Summary

      The ABOUT™—Perceived Risk is a self-report instrument, developed by Philip Morris Products S.A., designed to assess perceived risks associated with the use of a wide range of tobacco- and/or nicotine-containing products (TNP), such as cigarettes, e-cigarettes, smokeless tobacco, and heated tobacco products, as well as perceived risk associated with the use of nicotine replacement therapies (NRT) or remaining risks after smoking cessation. In this presentation a brief history of the development and evaluation of the ABOUT™— Perceived Risk will be presented, starting with the original conceptual framework developed on the basis of qualitative studies, literature review, and input from experts to the initial psychometric validation of two multi-item scales for Perceived Health Risk and Addiction Risk, respectively, and three single items for “harm to others.” To keep the instrument fit-for-purpose and to adapt to a growing population of dual and poly TNP users, further cognitive debriefing interviews and quantitative studies were conducted to validate 1) additional scales (Social and Practical Risk), 2) new versions of products to be assessed (current use of two or more TNPs; remaining risk after quitting all tobacco use), and 3) a short form (9-items) of the Perceived Health Risk scale. As for the original instrument edition, the new edition including all the updates to the instrument will be made available through PROQOLID™.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.